0.00Open0.00Pre Close0 Volume0 Open Interest45.00Strike Price0.00Turnover0.00%IV36.42%PremiumApr 25, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma108.89Leverage Ratio--Theta--Rho--Eff Leverage--Vega
DexCom Stock Discussion
Should boost Dexcom since Realtime monitoring will complement the pill for effect.
Game-Changing FDA Approval: Dexcom's New 15-Day Diabetes Monitor Sets Industry Record
U.S. equities, however, faced a turbulent Q1, rattled by the unpredictability of Trump-era po...
No comment yet